Point-of-Care Assays for Infliximab Therapeutic Drug Monitoring in Patients with IBD: Is Quicker Better?

被引:0
|
作者
Levitte, Steven [1 ]
机构
[1] Stanford Univ, Div Pediat Gastroenterol Hepatol & Nutr, 750 Welch Rd Ste 116, Palo Alto, CA 94304 USA
关键词
D O I
10.1007/s10620-023-08140-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [21] Nurse led therapeutic drug monitoring (TDM) of Infliximab in IBD
    Gleeson, S.
    Sugrue, K.
    Buckley, M.
    McCarthy, J.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S667 - S667
  • [22] ULTRA-PROACTIVE THERAPEUTIC DRUG MONITORING INCORPORATING INFLIXIMAB POINT-OF-CARE TESTING WITH AD HOC DOSE ADJUSTMENT REDUCES C-REACTIVE PROTEIN LEVELS IN PATIENTS WITH IBD DURING INFLIXIMAB MAINTENANCE TREATMENT
    Bossuyt, Peter
    Hoefkens, Eveline
    Geerts, Inge
    Verbiest, Freija
    Vermeulen, Edith
    August-Van Olmen
    Pouillon, Lieven
    GASTROENTEROLOGY, 2019, 156 (06) : S1136 - S1136
  • [23] Ultra-proactive therapeutic drug monitoring incorporating infliximab point-of-care testing with ad hoc dose adjustment reduces C-reactive protein levels in patients with IBD during infliximab maintenance treatment
    Bossuyt, P.
    Hoefkens, E.
    Geerts, I.
    Verbiest, F.
    Vermeulen, E.
    Van Olmen, A.
    Pouillon, L.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S378 - S378
  • [24] Comparison of the Quantum Blue® reader Point-of-Care system versus ELISA technique for therapeutic drug monitoring of Infliximab levels
    Novakovic, Vasilije
    Abdija, Samire
    Larsen, Pia Bukmann
    Fenger, Mogens
    Gredal, Lene
    Jacobsen, Katja Kemp
    CLINICAL BIOCHEMISTRY, 2019, 74 : 73 - 75
  • [25] Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs
    Taddeo, Adriano
    Prim, Denis
    Bojescu, Elena-Diana
    Segura, Jean-Manuel
    Pfeifer, Marc E.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2020, 5 (04): : 738 - 761
  • [26] Point-of-Care 3-D Printed Spectrophotometer for Therapeutic Drug Monitoring in Tuberculosis Patients
    Hooda, Pragya
    Sami, Muhammad A.
    Hassan, Umer
    IEEE SENSORS LETTERS, 2021, 5 (09)
  • [27] Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases
    Ordutowski, Henry
    Dal Dosso, Francesco
    De Wispelaere, Wout
    Van Tricht, Charlotte
    Vermeire, Severine
    Geukens, Nick
    Gils, Ann
    Spasic, Dragana
    Lammertyn, Jeroen
    BIOSENSORS & BIOELECTRONICS, 2022, 208
  • [28] THERAPEUTIC DRUG MONITORING FOR INFLIXIMAB & ADALIMUMAB IN IBD: PRACTICE PATTERNS, UNDERSTANDING & INTERPRETATION
    Samaan, Mark
    Arkir, Zehra
    Irving, Peter
    Chuter, Charlotte
    GUT, 2018, 67 : A90 - A91
  • [29] UTILIZATION OF THE BIOTRACK-516 SYSTEM IN POINT-OF-CARE THERAPEUTIC DRUG-MONITORING
    GARNETT, WR
    JOURNAL OF CLINICAL LIGAND ASSAY, 1995, 18 (01): : 43 - 48
  • [30] Design of point-of-care electrochemical sensor for therapeutic drug monitoring of ofloxacin in biological fluids
    Kelani, Khadiga M.
    Fayez, Yasmin Mohammed
    Gad, Asmaa G.
    Mahmoud, Amr M.
    JOURNAL OF ANALYTICAL SCIENCE AND TECHNOLOGY, 2024, 15 (01)